▽Pharmaceutical Business Review - Industry News, Information, Research ●04/17 21:40 April 17, 2025Glycomine secures $115m funding for Phase IIb trial of rare disease drugUS-based biotechnology company Glycomine has secured $115m in Series C funding to progress the mannose-1-phosphate replacement therapy GLM101 into a randomised Phase IIb trial.April 16, 2025Norgine agrees to acquire TheraviaApril 15, 2025INmune Bio, CGT Catapult to set up manufacturing for cell therapy plat